A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer

Clinical trial NCT04439890 · UNKNOWN

Trial details

NCT number: NCT04439890
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Non-squamous Cell Non-small Cell Lung Cancer

Start date: 2019-08-08
Primary completion: 2021-06-01
Enrollment: 369

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.